Course Overview
This 1.5-hour webinar will discuss how the CNS can utilize pharmaceutical guidelines treat heart failure with reduced ejection fraction. It will also discuss how CNSs should implement and optimize dosing of the 4 pillars of heart failure.

Continuing Education Credits
This nursing continuing professional development activity was approved by Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center's Commission on Accreditation. Completing of this course will earn you 1.5 contact hour(s) (Pharmacology Credit: 1.5)

Successful completion of this program requires that all components of this course are successfully completed, including the CE Evaluation and that the post-test is passed with at least an 85%. Contact Hours for this course will be offered through 10/11/2025.

The presenter, Nancy Albert, has previously received research grants from Novartis and Astra Zeneca.  She has participated as a paid consultant and speaker for Merck, Astra Zeneca, Boehringer Ingelheim/Eli Lilly, Daiichi, Cytokinetics, and Boston Scientific. All of the relevant financial relationships listed for this individual have been mitigated.

None of the planners for this educational activity have relevant financial relationships to disclose with ineligible companies.

Additional Course Information
Content is accessed on demand and can be completed all at once or over 90 days. After 90 days, access to the course will end and require repurchasing to complete. Instructions for how to access the course is sent via email after registration.

Cancellation requests must be made in writing to info@nancns.org within 14 days of purchase and are refunded minus a 20% cancellation fee. No cancellations are accepted after the course has been accessed or after the 14-day window.